ENTRY       D11597                      Drug
NAME        Ravagalimab (USAN/INN)
FORMULA     C6482H10014N1734O2024S42
EXACT_MASS  145874.2244
MOL_WEIGHT  145964.002
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVKPGGSLRL SCAASGFTFS DYGMNWVRQA PGKGLEWIAY ISSGRGNIYY
            ADTVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARSW GYFDVWGQGT TVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PEAAGGPSVF
            LFPPKPKDQL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVLHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIVMTQSPDS LAVSLGERAT INCKSSQSLL NRGNQKNYLT WFQQKPGQPP KLLIYWASTR
            ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQNDYTY PLTFGQGTKL EIKRTVAAPS
            VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
            LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
            (Disulfide bridge: H22-H96, H143-H199, H219-L220, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'220, H'260-H'320, H'366-H'424, L23-L94, L140-L200, L'23-L'94, L'140-L'200)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Anti-CD40 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of inflammatory and autoimmune diseases
TARGET      TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  PATHWAY   hsa04060(958)  Cytokine-cytokine receptor interaction
            hsa04514(958)  Cell adhesion molecules
            hsa04620(958)  Toll-like receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF5 (CD40)
                 D11597  Ravagalimab (USAN/INN)
DBLINKS     CAS: 2050816-56-1
            PubChem: 405226464
///
